Two years after reaching R1, Baylor’s research momentum continues to grow
…— Baylor professors are unlocking new understandings and treatments for diseases. For instance: Dr. Daniel Romo, the Schotts Professor of Chemistry at Baylor, is part of a team pursuing a groundbreaking drug to treat hypoxic-ischemic brain injury, which affects approximately 2 in every 1,000 U.S. newborns. Romo provides synthetic chemistry leadership for an international team of researchers pursuing the treatment. Romo’s colleague, Dr. Michael Tr…